These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 204803)

  • 41. Letter: The "pill" and myocardial infarction.
    Wallach G
    Conn Med; 1974 Dec; 38(12):669. PubMed ID: 4434751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stroke in users of low-dose oral contraceptives.
    Petitti DB; Sidney S; Bernstein A; Wolf S; Quesenberry C; Ziel HK
    N Engl J Med; 1996 Jul; 335(1):8-15. PubMed ID: 8637557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study.
    Dunn NR; Arscott A; Thorogood M
    Contraception; 2001 Feb; 63(2):65-9. PubMed ID: 11292469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular issues with oral contraceptives: evidenced-based medicine.
    Burkman RT
    Int J Fertil Womens Med; 2000; 45(2):166-74. PubMed ID: 10831186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cigarette smoking in relation to the risk of myocardial infarction in young women. Modifying influence of age and predisposing factors.
    Rosenberg L; Shapiro S; Kaufman DW; Slone D; Miettinen OS; Stolley PD
    Int J Epidemiol; 1980 Mar; 9(1):57-63. PubMed ID: 7419331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A review: adverse effects of oral contraceptives.
    Tsung SH; Loh WP
    J Indiana State Med Assoc; 1979 Aug; 72(8):578-80. PubMed ID: 229169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women.
    Margolis KL; Adami HO; Luo J; Ye W; Weiderpass E
    Fertil Steril; 2007 Aug; 88(2):310-6. PubMed ID: 17624338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors.
    Petitti DB; Wingerd J; Pellegrin F; Ramcharan S
    JAMA; 1979 Sep; 242(11):1150-4. PubMed ID: 470067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Angiography findings following myocardial infarct in young females: the role of oral contraceptives].
    Engel HJ; Engel E; Behnke K; Lichtlen P
    Herz; 1987 Aug; 12(4):290-5. PubMed ID: 3653838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute coronary artery disease and oral contraceptives.
    Friedlander DH; Snell AP
    Aust N Z J Med; 1975 Feb; 5(1):12-6. PubMed ID: 1057908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral contraception and myocardial infarction revisited: the effects of new preparations and prescribing patterns.
    Adam SA; Thorogood M; Mann JI
    Br J Obstet Gynaecol; 1981 Aug; 88(8):838-45. PubMed ID: 7260005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral contraceptive use in relation to nonfatal myocardial infarction.
    Rosenberg L; Hennekens CH; Rosner B; Belanger C; Rothman KJ; Speizer FE
    Am J Epidemiol; 1980 Jan; 111(1):59-66. PubMed ID: 7352460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of myocardial infarction in oral-contraceptive users.
    Jick H
    Lancet; 1979 Oct; 2(8146):800. PubMed ID: 90899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Myocardial infarction following administration of oral contraceptive agents. 3 cases].
    Benacerraf A; Veron P; Morin B; Castillo-Fenoy A; Chapuis A; Ziskind B
    Nouv Presse Med; 1977 Jan; 6(1):22-6. PubMed ID: 834545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral contraceptives use and the risk of myocardial infarction: a meta-analysis.
    Khader YS; Rice J; John L; Abueita O
    Contraception; 2003 Jul; 68(1):11-7. PubMed ID: 12878281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Myocardial infarct and oral contraceptives].
    Baudet M; Maisonneuve D; Normand JP; Boschat J; Mathivat A
    Ann Med Interne (Paris); 1978; 129(6-7):459-62. PubMed ID: 686585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.